Literature DB >> 12827470

The matrix protein of Human respiratory syncytial virus localises to the nucleus of infected cells and inhibits transcription.

R Ghildyal1, C Baulch-Brown, J Mills, J Meanger.   

Abstract

We studied the kinetics of localisation of matrix (M) protein of Human respiratory syncytial virus (RSV) in infected cells. M protein was detected in the nucleus early in infection, by confocal microscopy and by immunoblotting of nuclear fractions. We next tested the possibility that M protein may be involved in inhibition of host cell transcription. Nuclear extracts from RSV infected cells had less transcriptional activity in vitro when compared to nuclear extracts from mock infected cells. In addition, nuclear extracts from RSV infected cells inhibited the transcriptional activity of nuclear extracts from mock infected cells, suggesting that an inhibitory activity was transferred with nuclear extracts from RSV infected cells. Our data suggest that M protein may play a role early in the infection by inhibiting host cell transcription.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12827470     DOI: 10.1007/s00705-003-0112-y

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  42 in total

1.  The human respiratory syncytial virus matrix protein is required for maturation of viral filaments.

Authors:  Ruchira Mitra; Pradyumna Baviskar; Rebecca R Duncan-Decocq; Darshna Patel; Antonius G P Oomens
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

2.  RNA interference with measles virus N, P, and L mRNAs efficiently prevents and with matrix protein mRNA enhances viral transcription.

Authors:  Thorsten Reuter; Benedikt Weissbrich; Sibylle Schneider-Schaulies; Jürgen Schneider-Schaulies
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

3.  Surface features of a Mononegavirales matrix protein indicate sites of membrane interaction.

Authors:  Victoria A Money; Helen K McPhee; Jackie A Mosely; John M Sanderson; Robert P Yeo
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-26       Impact factor: 11.205

4.  Viral degradasome hijacks mitochondria to suppress innate immunity.

Authors:  Ramansu Goswami; Tanmay Majumdar; Jayeeta Dhar; Saurabh Chattopadhyay; Sudip K Bandyopadhyay; Valentina Verbovetskaya; Ganes C Sen; Sailen Barik
Journal:  Cell Res       Date:  2013-07-23       Impact factor: 25.617

5.  The respiratory syncytial virus fusion protein targets to the perimeter of inclusion bodies and facilitates filament formation by a cytoplasmic tail-dependent mechanism.

Authors:  Pradyumna S Baviskar; Anne L Hotard; Martin L Moore; Antonius G P Oomens
Journal:  J Virol       Date:  2013-07-31       Impact factor: 5.103

Review 6.  Nipah virus matrix protein: expert hacker of cellular machines.

Authors:  Ruth E Watkinson; Benhur Lee
Journal:  FEBS Lett       Date:  2016-07-12       Impact factor: 4.124

7.  Crystal structure of the Borna disease virus matrix protein (BDV-M) reveals ssRNA binding properties.

Authors:  Piotr Neumann; Diana Lieber; Sylke Meyer; Philipp Dautel; Andreas Kerth; Ina Kraus; Wolfgang Garten; Milton T Stubbs
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

8.  Borna disease virus matrix protein is an integral component of the viral ribonucleoprotein complex that does not interfere with polymerase activity.

Authors:  Geoffrey Chase; Daniel Mayer; Antonia Hildebrand; Ronald Frank; Yohei Hayashi; Keizo Tomonaga; Martin Schwemmle
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

9.  The respiratory syncytial virus matrix protein possesses a Crm1-mediated nuclear export mechanism.

Authors:  Reena Ghildyal; Adeline Ho; Manisha Dias; Lydia Soegiyono; Phillip G Bardin; Kim C Tran; Michael N Teng; David A Jans
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

10.  Ubiquitin-regulated nuclear-cytoplasmic trafficking of the Nipah virus matrix protein is important for viral budding.

Authors:  Yao E Wang; Arnold Park; Michael Lake; Mickey Pentecost; Betsabe Torres; Tatyana E Yun; Mike C Wolf; Michael R Holbrook; Alexander N Freiberg; Benhur Lee
Journal:  PLoS Pathog       Date:  2010-11-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.